Financials

  • Market Capitalization 7.58 M
  • Employee 8
  • Founded 2017
  • CEO N/A
  • Website www.cnspharma.com
  • Headquarter Nevada, United States
  • FIGI BBG00PM24T16
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.15
Fiyat/satışlar oranı
-909.61

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
4738
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.88 USD-8.10%-4.13%+10.66%+674.60%7.65 M USD
4739
SNGX
Soligenix, Inc. - Common Stock
0.35 USD-2.78%-2.78%-5.41%-69.03%7.62 M USD
4746
INM
InMed Pharmaceuticals Inc. - Common Shares
1.36 USD0.00%+1.49%+5.43%-36.15%7.47 M USD
4748
APRE
Aprea Therapeutics, Inc. - Common Stock
0.64 USD+8.47%-4.48%-16.88%-57.62%8.06 M USD

Haberler